Chlorhexidine release from poly(epsilon-caprolactone) films prepared by solvent evaporation

被引:36
作者
Medlicott, NJ
Tucker, IG
Rathbone, MJ
Holborow, DW
Jones, DS
机构
[1] UNIV OTAGO,SCH PHARM,POB 913,DUNEDIN,NEW ZEALAND
[2] UNIV OTAGO,SCH DENT,DEPT PERIODONTOL,DUNEDIN,NEW ZEALAND
[3] QUEENS UNIV BELFAST,SCH PHARM,BELFAST,ANTRIM,NORTH IRELAND
关键词
chlorhexidine; poly(epsilon-caprolactone) films; formulation variables; release; complete factorial;
D O I
10.1016/S0378-5173(96)04675-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of selected formulation variables on the release of chlorhexidine from poly(epsilon-caprolactone) films was evaluated in vitro using a complete factorial experimental design. Repeated measures analysis of variance showed chlorhexidine type (diacetate or base), drug load (10, 20 or 30% w/w), chlorhexidine particle size (< 63 or 63-125 mu m) and film side (upper or lower) significantly affected the percentage released over 10 and 30 days. Significant interactions were also observed between factors. Release from the upper side of films occurred more slowly than from the lower side of films for most formulations. This difference was particularly apparent for films containing chlorhexidine diacetate. The general release equation (M(t)/M(infinity) = kt(n)) was fitted to the release data and constants estimated. The value of n, which indicates the mechanism of release, tended towards 0.5 for release at high drug loadings which may suggest release was predominantly diffusion-controlled from these films. Transecting sections of film, prepared with chlorhexidine diacetate < 63 mu m (drug loading 20% w/w), and analysing the chlorhexidine content at varying distances from the film surfaces showed a gradient in chlorhexidine concentration through the film, with lower concentrations near the upper side and higher concentrations near the lower side.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 28 条
[1]  
[Anonymous], PHARM STAT PRACTICAL
[2]  
Baker R.W., 1987, CONTROLLED RELEASE B
[3]   RETENTION OF CHLORHEXIDINE IN HUMAN ORAL CAVITY AFTER MOUTH RINSES [J].
BONESVOLL, P ;
LOKKEN, P ;
ROLLA, G ;
PAUS, PN .
ARCHIVES OF ORAL BIOLOGY, 1974, 19 (03) :209-212
[4]   ORAL PHARMACOLOGY OF CHLORHEXIDINE [J].
BONESVOLL, P .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1977, 4 (05) :49-65
[5]  
BONNY JD, 1991, PHARM ACTA HELV, V66, P160
[6]   INVESTIGATION OF FACTORS INFLUENCING RELEASE OF SOLID DRUG DISPERSED IN INERT MATRICES [J].
DESAI, SJ ;
SIMONELL.AP ;
HIGUCHI, WI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (10) :1459-&
[7]   A REVIEW OF THE LITERATURE ON USE OF CHLORHEXIDINE IN DENTISTRY [J].
FARDAL, O ;
TURNBULL, RS .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1986, 112 (06) :863-869
[8]   FORMULATION OF SUSTAINED-RELEASE PROMETHAZINE HYDROCHLORIDE TABLETS USING HYDROXYPROPYLMETHYLCELLULOSE MATRICES [J].
FORD, JL ;
RUBINSTEIN, MH ;
HOGAN, JE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 24 (2-3) :327-338
[9]   MONOLITHIC TETRACYCLINE-CONTAINING FIBERS FOR CONTROLLED DELIVERY TO PERIODONTAL POCKETS [J].
GOODSON, JM ;
HOLBOROW, D ;
DUNN, RL ;
HOGAN, P ;
DUNHAM, S .
JOURNAL OF PERIODONTOLOGY, 1983, 54 (10) :575-579
[10]   MODELING OF SUSTAINED-RELEASE OF WATER-SOLUBLE DRUGS FROM POROUS, HYDROPHOBIC POLYMERS [J].
GURNY, R ;
DOELKER, E ;
PEPPAS, NA .
BIOMATERIALS, 1982, 3 (01) :27-32